21 CFR 20.48
§ 20.48 Judicial review of proposed disclosure.
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 20.48, § 20.48 Judicial review of proposed disclosure, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/83324
- Permanent ID
ys:prov:83324@1- SHA-256
be87f8243a8301418e5ded6e3bc5cca5fe3066d7cc8180db2d93a7fab00cc408
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
Where the Food and Drug Administration consults with a person who will be affected by a proposed disclosure of data or information contained in Food and Drug Administration records pursuant to § 20.47, and rejects the person's request that part or all of the records not be made available for public disclosure, the decision constitutes final agency action that is subject to judicial review pursuant to 5 U.S.C. chapter 7. The person affected will be permitted 5 days after receipt of notification of such decision within which to institute suit in a United States District Court to enjoin release of the records involved. If suit is brought, the Food and Drug Administration will not disclose the records involved until the matter and all related appeals have been concluded.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.